Tag - AKCA

Executive Moves

Akcea names Damien Devitt as CEO

Damien Devitt, who has been interim CEO of Akcea Therapeutics (NASDAQ:AKCA) since September 2019, has been promoted to CEO, effective immediately, and will continue to serve as a member of Akcea’s board. “With his...

March 24, 2020

Developments

Akcea reports positive topline Phase 2 data from cardiometabolic disease trial

Akcea Therapeutics (NASDAQ:AKCA) reported positive topline results from its Phase 2 study of AKCEA-ANGPTL3-LRx in patients with hypertriglyceridemia, Type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). ...

January 28, 2020

Tag - AKCA

Akcea names Damien Devitt as CEO

Akcea reports positive topline Phase 2 data from cardiometabolic disease trial

General

More